Company intelligence / Profile preview

Oncomfort

Ownership: Private
Development stage: Commercial

Overview

Oncomfort developed and commercialized CE-approved digital sedation solutions combining virtual reality with clinical hypnosis for pain and anxiety management. Their technology has been adopted by numerous healthcare facilities across Europe. The company was acquired by HypnoVR in October 2023. Clinical results have demonstrated efficacy in reducing patient pain and anxiety without medication.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (specifically digital sedation using virtual reality and clinical hypnosis)
Industry: Digital Health Medical Devices

Partnerships

Debiopharm International SA (investor/partner)

Beyond the preview

Go deeper on Oncomfort.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncomfort.

Explore the full profile